Skip to main content
. Author manuscript; available in PMC: 2023 May 31.
Published in final edited form as: Arthritis Care Res (Hoboken). 2022 Mar 1;74(4):505–520. doi: 10.1002/acr.24839

Table 7:

Medication Monitoring*

Methotrexate**# Sulfasalazine** Leflunomide# Tocilizumab Anakinra Tofacitinib Canakinumab NSAIDs** Hydroxychloroquine TNFi Abatacept
CBC /diff and LFTs
-Baseline
-1-2 months after starting
-Every 3-4 months thereafter***
X X X X X X X
CBC/diff and LFTs
-Baseline
-Every 6-12 months
X
CBC/diff and LFTs
-Baseline
-Once yearly
X X
Lipid panel
-Baseline
-Every 6 months
X
Lipid panel
-Baseline
-4-8 weeks after starting
X
Eye exam
-Baseline
-Once yearly
X
None required X
*

If patient is on more than one medication, a more restrictive schedule should be used

**

Include renal function with lab work

***

Should be rechecked sooner if dose increased

#

Pregnancy test should be considered before use, and counseling as to use of effective methods of contraception is recommended